Journal
PHARMACOGENOMICS JOURNAL
Volume 18, Issue 5, Pages 633-645Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41397-018-0016-6
Keywords
-
Categories
Funding
- Seoul National University Hospital Research Fund [0320150110 (2015-1126)]
- Seoul National University Hospital (2017)
Ask authors/readers for more resources
Membrane transporters can be major determinants of the pharmacokinetic profiles of anticancer drugs. The associations between genetic variations of ATP-binding cassette (ABC) and solute carrier (SLC) genes and cancer survival were investigated through a meta-analysis and an association study in the Seoul Breast Cancer Study (SEBCS). Including the SEBCS, the meta-analysis was conducted among 38 studies of genetic variations of transporters on various cancer survivors. The population of SEBCS consisted of 1338 breast cancer patients who had been treated with adjuvant chemotherapy. A total of 7750 SNPs were selected from 453 ABC and/or SLC genes typed by an Affymetrix 6.0 chip. ABCB1 rs1045642 was associated with poor progression-free survival in a meta-analysis (HR = 1.33, 95% CI: 1.07-1.64). ABCB1, SLC8A1, and SLC12A8 were associated with breast cancer survival in SEBCS (P-gene < 0.05). ABCB1 rs1202172 was differentially associated with survival depending on the chemotherapy (P-interaction = 0.035). Our finding provides suggestive associations of membrane transporters on cancer survival.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available